Myoclonic atonic epilepsy
Another generalized epilepsy syndrome that is "not so" generalized Myoclonic atonic/astatic epilepsy (MAE), first described well by Doose 1 (pronounced dough sah: http://www. youtube.com/watch?v5hNNiWXV2wF0), is a generalized electroclinical syndrome with early onset characterized by myoclonic, atonic/astatic, generalized tonic-clonic, and absence seizures (but not tonic seizures) in association with generalized spike-wave (GSW) discharges. Thought to have a genetic component that has proven to be complicated, 2 MAE sometimes occurs in children who have otherwise been developing normally and has variable outcome. MAE is typically treated with antiseizure medications that are used for generalized epilepsy syndromes, with perhaps a best response to valproate, felbamate, or the ketogenic diet. 3, 4 In this issue of Neurology ® , Moeller et al. 5 report on the fMRI correlates of GSW discharges as measured with simultaneous EEG during sleep in children with a clinical diagnosis of MAE. They were able to obtain blood oxygen level-dependent (BOLD) fMRI signal changes in most individual participants. This study, like other EEG-fMRI studies of the generalized epilepsies, shows that fMRI activations involve selective brain networks that are more localized than the widespread EEG discharges associated with generalized epilepsies. Group fMRI analysis showed BOLD signal increases in the thalamus, putamen, and premotor cortex, with BOLD signal decreases in nodes of the default mode network (posterior cingulate/precuneus and lateral parietal cortex/inferior parietal lobule). In addition to the common brain networks highlighted in other generalized epilepsy syndromes with thalamic activation and posterior cingulate/precuneus deactivation, children with MAE have prominent activation of nodes of the motor network, consistent with the motor features of the common myoclonic atonic/astatic seizures seen in this distinctive electroclinical syndrome.
More generally, the results of this study are in line with a broadly developing theme in the study of childhood generalized epilepsy syndromes. EEG-fMRI studies of childhood absence epilepsy have shown predominant thalamic activation and default mode network deactivation.
6-8 Even Lennox-Gastaut syndrome, a devastating epileptic encephalopathy with EEG findings of runs of slow spike and wave and paroxysmal higher frequency activity, has fMRI correlates that are more focal than expected in a syndrome with widespread EEG abnormalities. 9, 10 EEG-fMRI is maturing as a research and clinical technique. Recording scalp EEG in an electrically hostile environment is not an easy task. Substantial technical artifacts, such as changing imaging gradients and ballistocardiogram (ECG-linked artifact observed in the scalp electrodes), contaminate the EEG signal. However, the relatively distinctive EEG discharges in patients with epilepsy have partially circumvented this problem. EEG-fMRI even has applicability to young pediatric populations [6] [7] [8] and was performed by Moeller et al. 5 with chloral hydrate-induced sleep in mostly young children (ages 3-13 years, but mostly 3-5).
Clinically, EEG-fMRI is advancing in both technology and utilization across many types of epilepsy. EEG-fMRI localization is used increasingly in focal epilepsies, where more precise localization may lead to successful surgical treatment.
11 EEG-fMRI may eventually have clinical utility in the generalized epilepsies, for both treatment and diagnosis. The response to treatment with valproate, for example, is related to the generator of the GSW discharge. 12 EEG-fMRI may be particularly helpful diagnostically by providing a biomarker for distinguishing subtypes of these often overlapping generalized epilepsy syndromes. The BOLD signal fingerprint may provide both syndrome-and patient-specific information as the underlying causes of the many related generalized syndromes are better understood. 13 
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